Buscar
Mostrando ítems 1-10 de 31
Prolactin and its receptor as therapeutic targets in glioblastoma multiforme
(Nature Publishing Group, 2019-12)
Although prolactin (PRL) and its receptor (PRLR) have been detected in glioblastoma multiforme (GBM), their role in its pathogenesis remains unclear. Our aim was to explore their contribution in GBM pathogenesis. We detected ...
A heterotypic tridimensional model to study the interaction of macrophages and glioblastoma in vitro
(Molecular Diversity Preservation International, 2021-05)
Background: Glioblastoma multiforme (GBM) is the most frequent and aggressive primary brain tumor, and macrophages account for 30–40% of its composition. Most of these macrophages derive from bone marrow monocytes playing ...
Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, on the Human Glioblastoma T98G Cells
(SAGE Publications Inc., 2019-12)
Glioblastoma multiforme is the most aggressive brain tumor, and human T98G cells constitute a useful glioblastoma multiforme model to evaluate the chemotherapeutic agents. Modern life (shiftwork, jetlag, etc.) may cause ...
Chemotherapeutic effect of SR9009, a REV-ERB agonist, on the human glioblastoma T98G cells
(SAGE Publications Inc., 2019-11)
Glioblastoma multiforme is the most aggressive brain tumor, and human T98G cells constitute a useful glioblastoma multiforme model to evaluate the chemotherapeutic agents. Modern life (shiftwork, jetlag, etc.) may cause ...
Effectiveness of ZnPc and of an amine derivative to inactivate Glioblastoma cells by Photodynamic Therapy: An in vitro comparative study
(Nature Publishing Group, 2019-12)
Glioblastoma multiforme is considered to be one of the most aggressive types of tumors of the central nervous system, with a poor prognosis and short survival periods of ~ one year. The current protocol for glioblastoma ...
Study of resistance to chemotherapy mediated by abc transporters in biopsies of glioblastoma multiformeREVISTA MEDICA DE CHILEREV MED CHILE
(SOCIEDAD MEDICA DE SANTIAGO, 2016)